Inventor · disambiguated record
R. Jeffrey Neitz
Also filed as: NEITZ R J · NEITZ R JEFFREY
21 granted patents·20 pending applications·72 citations·filing 1997–2021
94Inventor score
Files withATHENA NEUROSCIENCES INC8IMAGO PHARMACEUTICALS INC8ELAN PHARM INC5UNIV CALIFORNIA4GALEMMO ROBERT A2
Top patents by PatentIndex Score
41 records- 0191US6653303B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2003·Granted Nov 25, 2003·16 cites·30 claims
- 0289US6544978B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Apr 8, 2003·16 cites·32 claims
- 0387US6541466B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Apr 1, 2003·10 cites·32 claims
- 0477US2022081427A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0575US7417152B24-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseasesELAN PHARM INC·Filed 2004·Granted Aug 26, 2008·8 cites·11 claims
- 0675US7153847B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsLILLY CO ELI·Filed 2003·Granted Dec 26, 2006·3 cites·19 claims
- 0775US6559141B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted May 6, 2003·2 cites·32 claims
- 0870US9073891B2Inhibitors of Jun N-terminal kinaseSHAM HING L·Filed 2012·Granted Jul 7, 2015·1 cites·6 claims
- 0970US7432379B2Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonistsELAN PHARM INC·Filed 2004·Granted Oct 7, 2008·5 cites·12 claims
- 1070US2020277285A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1169US6951854B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsLILLY CO ELI·Filed 2004·Granted Oct 4, 2005·0 cites·13 claims
- 1269US2006079499A1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compoundsWU JING·Filed 2004·Application pending·0 cites
- 1368US2020039972A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1467US2019194176A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1566US6632811B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Oct 14, 2003·1 cites·13 claims
- 1665US6667305B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2003·Granted Dec 23, 2003·1 cites·13 claims
- 1765US2018319780A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1863US2018037577A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1962US9796706B2Inhibitors of Jun N-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·0 cites·17 claims
- 2062US6683075B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by useATHENA NEUROSCIENCES INC·Filed 2003·Granted Jan 27, 2004·2 cites·29 claims
- 2159US11247985B2Phenyl indole allosteric inhibitors of P97 ATPaseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2020·Granted Feb 15, 2022·0 cites·8 claims
- 2259US2013231335A1Inhibitors of polo-like kinaseELAN PHARM INC·Filed 2013·Application pending·0 cites
- 2359US2013331376A1Inhibitors of polo-like kinaseELAN CORP INC·Filed 2013·Application pending·0 cites
- 2458US9884828B2Substituted cinnolines as inhibitors of LRRK2 kinase activityAUBELE DANIELLE L·Filed 2012·Granted Feb 6, 2018·1 cites·23 claims
- 2557US6635632B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1997·Granted Oct 21, 2003·6 cites·60 claims
- 2657US2005182046A1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compoundsFiled 2004·Application pending·0 cites
- 2756US2015259330A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2853US10633370B2Phenyl indole allosteric inhibitors of p97 ATPaseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted Apr 28, 2020·0 cites·11 claims
- 2953US8450363B2Inhibitors of Jun N-terminal kinaseSHAM HING L·Filed 2010·Granted May 28, 2013·0 cites·25 claims
- 3053US2006217362A1Novel compounds useful for bradykinin B1 receptor antagonismTUNG JAY S·Filed 2005·Application pending·0 cites
- 3153US2025263366A2Caspase 6 inhibitors and uses thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 3252US2015126502A1Inhibitors of polo-like kinaseELAN PHARM INC·Filed 2015·Application pending·0 cites
- 3351US8541418B2Inhibitors of polo-like kinaseGALEMMO ROBERT A·Filed 2010·Granted Sep 24, 2013·0 cites·14 claims
- 3451US8445503B2Inhibitors of polo-like kinaseGALEMMO ROBERT A·Filed 2010·Granted May 21, 2013·0 cites·9 claims
- 3551US2023142739A1Protein-protein interaction stabilizersUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3649US2023052528A1Taspase1 inhibitors and uses thereofUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 3746US2014329863A1Novel antiprion compoundsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 3843US7906556B2Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitorsELAN PHARM INC·Filed 2006·Granted Mar 15, 2011·0 cites·18 claims
- 3937US2012115848A1Inhibitors of Polo-Like KinaseGALEMMO JR ROBERT A·Filed 2011·Application pending·0 cites
- 4037US2005261273A1Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 4134US2005239790A1Substituted hydroxyethylamine aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when R. Jeffrey Neitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →